Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G1XCGD Gene Therapy for X-Linked Chronic Granulomatous Disease
NCT02234934Phase 2Completed
- Sponsor
- University of California, Los Angeles
- Start
- Oct 2015
- Primary completion
- Sep 2024
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of G1XCGD in X-linked chronic granulomatous disease (X-CGD), sponsored by University of California, Los Angeles. Started Oct 2015; status: completed.
02
Drugs
G1XCGD
03
Conditions
X-linked chronic granulomatous disease (X-CGD)
Beyond the preview
Go deeper on NCT02234934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02234934.